Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Strike

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
BMJ Open|August 3, 2018
Defining and measuring health equity effects in research on task shifting interventions in high-income countries: a systematic review protocolAaron M Orkin, Allison McArthur, André McDonald, et al.
Journal of the International AIDS Society|October 8, 2025
"From an HCV and HIV point of view, it's been remarkable": A qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, CanadaAdrian Guta, Katherine Rudzinski, Marilou Gagnon, et al.
Harm Reduction Journal|November 17, 2022
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital settingKatherine Rudzinski, Soo Chan Carusone, Andre Ceranto, et al.
BMJ Open|September 14, 2019
'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harmsPamela Leece, Triti Khorasheh, Nimitha Paul, et al.
Plos One|July 5, 2022
Resuscitation simulation among people who are likely to witness opioid overdose: Experiences from the SOONER TrialJonathan P Whittall, Aaron M Orkin, Curtis Handford, et al.
Addiction Science & Clinical Practice|October 22, 2025
Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains frameworkPamela Leece, Triti Khorasheh, Suzanne Zerger, et al.
Harm Reduction Journal|July 2, 2022
Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi methodMax Ferguson, Andrea Medley, Katherine Rittenbach, et al.
Harm Reduction Journal|July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworksElaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
The International Journal on Drug Policy|February 4, 2019
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in CanadaElaine Hyshka, Jalene Anderson-Baron, Arlanna Pugh, et al.
BMJ Public Health|December 1, 2025
COVID-19 immunisation among individuals with opioid use disorder in Ontario: a population-based cohort studyMelina Hanna, Anna Maria Subic, Alison L Park, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
BMJ Open|August 3, 2018
Defining and measuring health equity effects in research on task shifting interventions in high-income countries: a systematic review protocolAaron M Orkin, Allison McArthur, André McDonald, et al.
Journal of the International AIDS Society|October 8, 2025
"From an HCV and HIV point of view, it's been remarkable": A qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, CanadaAdrian Guta, Katherine Rudzinski, Marilou Gagnon, et al.
Harm Reduction Journal|November 17, 2022
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital settingKatherine Rudzinski, Soo Chan Carusone, Andre Ceranto, et al.
BMJ Open|September 14, 2019
'Communities are attempting to tackle the crisis': a scoping review on community plans to prevent and reduce opioid-related harmsPamela Leece, Triti Khorasheh, Nimitha Paul, et al.
Plos One|July 5, 2022
Resuscitation simulation among people who are likely to witness opioid overdose: Experiences from the SOONER TrialJonathan P Whittall, Aaron M Orkin, Curtis Handford, et al.
Addiction Science & Clinical Practice|October 22, 2025
Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains frameworkPamela Leece, Triti Khorasheh, Suzanne Zerger, et al.
Harm Reduction Journal|July 2, 2022
Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi methodMax Ferguson, Andrea Medley, Katherine Rittenbach, et al.
Harm Reduction Journal|July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworksElaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
The International Journal on Drug Policy|February 4, 2019
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in CanadaElaine Hyshka, Jalene Anderson-Baron, Arlanna Pugh, et al.
BMJ Public Health|December 1, 2025
COVID-19 immunisation among individuals with opioid use disorder in Ontario: a population-based cohort studyMelina Hanna, Anna Maria Subic, Alison L Park, et al.
Pageof 15